Critical Role Played by Cyclin D3 in the MyoD-Mediated Arrest of Cell Cycle during Myoblast Differentiation

REFERENCES

• Andres, V., and J. Walsh 1996. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J. Cell Biol. 132:657–666.
   PubMedGoogle Scholar
• Arany, Z., D. Newsome, E. Oldread, D. M. Livingston, and J. Eckner 1995. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374:81–84.
   PubMed Web of Science ®Google Scholar
• Bader, D., T. Masaki, and J. Fischman 1982. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J. Cell Biol. 95:763–770.
   PubMed Web of Science ®Google Scholar
• Bartkova, J., J. Lukas, M. Strauss, and J. Bartek 1998. Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene 17:1027–1037.
   PubMedGoogle Scholar
• Botz, J., K. Zerfass-Thome, D. Spitkovsky, H. Delius, B. Vogt, M. Eilers, A. Hatzigeorgiou, and J. Jansen-Dürr 1996. Cell cycle regulation of the murine cyclin E gene depends on an E2F binding site in the promoter. Mol. Cell. Biol. 16:3401–3409.
   PubMed Web of Science ®Google Scholar
• Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248–254.
   PubMed Web of Science ®Google Scholar
• Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and J. Kouzarides 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597–601.
   PubMed Web of Science ®Google Scholar
• Buckingham, M. 1992. Making muscle in mammals. Trends Genet. 8:144–148.
   PubMed Web of Science ®Google Scholar
• Cardoso, M. C., H. Leonhardt, and J. Nadal-Ginard 1993. Reversal of terminal differentiation and control of DNA replication: cyclin A and Cdk2 specifically localize at subnuclear sites of DNA replication. Cell 74:979–992.
   PubMedGoogle Scholar
• Caruso, M., F. Martelli, A. Giordano, and J. Felsani 1993. Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein. Oncogene 8:267–278.
   PubMedGoogle Scholar
• Chomczynski, P., and J. Sacchi 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156–159.
   PubMed Web of Science ®Google Scholar
• Davis, R. L., and J. Weintraub 1992. Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12. Science 256:1027–1030.
   PubMed Web of Science ®Google Scholar
• DeGregori, J., T. Kowalik, and J. Nevins 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15:4215–4224.
   PubMed Web of Science ®Google Scholar
• de Wet, J. R., K. V. Wood, M. DeLuca, D. R. Helinski, and J. Subramani 1987. Firefly luciferase gene: structure and expression in mammalian cells. Mol. Cell. Biol. 7:725–737.
   PubMed Web of Science ®Google Scholar
• Dowdy, S. F., P. W. Hinds, K. Louie, S. I. Reed, A. Arnold, and J. Weinberg 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499–511.
   PubMed Web of Science ®Google Scholar
• Eckner, R., M. E. Ewen, D. Newsome, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and J. Livingston 1994. Molecular cloning and functional analysis of the adenovirus E1A- associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869–884.
   PubMed Web of Science ®Google Scholar
• Eckner, R., T. P. Yao, E. Oldread, and J. Livingston 1996. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10:2478–2490.
   PubMed Web of Science ®Google Scholar
• Emerson, C. P. 1993. Skeletal myogenesis: genetics and embryology to the fore. Curr. Opin. Genet. Dev. 3:265–274.
   PubMedGoogle Scholar
• Endo, T., and J. Goto 1992. Retinoblastoma gene product Rb accumulates during myogenic differentiation and is deinduced by the expression of SV40 large T antigen. J. Biochem. 112:427–430.
   PubMedGoogle Scholar
• Ewen, M. E., H. K. Sluss, C. J. Sherr, H. Matsushime, J. Kato, and J. Livingston 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487–497.
   PubMed Web of Science ®Google Scholar
• Geng, Y., E. N. Eaton, M. Picon, J. M. Roberts, A. S. Lundberg, A. Gifford, C. Sardet, and J. Weinberg 1996. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12:1173–1180.
   PubMed Web of Science ®Google Scholar
• Girard, F., U. Strausfeld, A. Fernandez, and J. Lamb 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67:1169–1179.
   PubMed Web of Science ®Google Scholar
• Goldberg, A. L. 1995. Functions of the proteasome: the lysis at the end of the tunnel. Science 268:522–523.
   PubMed Web of Science ®Google Scholar
• Graessmann, M., and J. Graessmann 1983. Microinjection of tissue culture cells. Methods Enzymol. 101:482–492.
   PubMed Web of Science ®Google Scholar
• Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and J. Nadal Ginard 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309–324.
   PubMed Web of Science ®Google Scholar
• Guo, K., and J. Walsh 1997. Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F. J. Biol. Chem. 272:791–797.
   PubMedGoogle Scholar
• Guo, K., J. Wang, V. Andres, R. C. Smith, and J. Walsh 1995. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol. Cell. Biol. 15:3823–3829.
   PubMed Web of Science ®Google Scholar
• Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and J. Lassar 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018–1021.
   PubMed Web of Science ®Google Scholar
• Harlow, E., B. R. Franza Jr., and J. Schley 1985. Monoclonal antibodies specific for adenovirus early region 1A proteins: extensive heterogeneity in early region 1A products. J. Virol. 55:533–546.
   PubMed Web of Science ®Google Scholar
• Harper, J. W., and J. Elledge 1996. Cdk inhibitors in development and cancer. Curr. Opin. Genet. Dev. 6:56–64.
   PubMed Web of Science ®Google Scholar
• Hochstrasser, M. 1995. Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol. 7:215–223.
   PubMed Web of Science ®Google Scholar
• Hollenberg, S. M., P. F. Cheng, and J. Weintraub 1993. Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination. Proc. Natl. Acad. Sci. USA 90:8028–8032.
   PubMedGoogle Scholar
• Jahn, L., J. Sadoshima, and J. Izumo 1994. Cyclins and cyclin-dependent kinases are differentially regulated during terminal differentiation of C2C12 muscle cells. Exp. Cell Res. 212:297–307.
   PubMedGoogle Scholar
• Kato, J., H. Matsushime, S. W. Hiebert, M. E. Ewen, and J. Sherr 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331–342.
   PubMed Web of Science ®Google Scholar
• Kiess, M., R. M. Gill, and J. Hamel 1995. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation. Cell Growth Differ. 6:1287–1298.
   PubMedGoogle Scholar
• Kiess, M., R. Montgomery Gill, and J. Hamel 1995. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent miotubes. Oncogene 10:159–166.
   PubMed Web of Science ®Google Scholar
• Lassar, A. B., S. X. Skapek, and J. Novitch 1994. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr. Opin. Cell Biol. 6:788–794.
   PubMed Web of Science ®Google Scholar
• Lee, J. O., A. A. Russo, and J. Pavletich 1998. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391:859–865.
   PubMed Web of Science ®Google Scholar
• Lundblad, J. R., R. P. Kwok, M. E. Laurance, M. L. Harter, and J. Goodman 1995. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374:85–88.
   PubMed Web of Science ®Google Scholar
• Luo, R. X., A. A. Postigo, and J. Dean 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463–473.
   PubMed Web of Science ®Google Scholar
• Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche, and J. Harel-Bellan 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601–605.
   PubMed Web of Science ®Google Scholar
• Maione, R., and J. Amati 1997. Interdependence between muscle differentiation and cell-cycle control. Biochim. Biophys. Acta 1332:M19–M30.
   PubMed Web of Science ®Google Scholar
• Maione, R., G. M. Fimia, P. Holman, B. Schaffhausen, and J. Amati 1994. Retinoblastoma anti-oncogene is involved in the inhibition of myogenesis by polyomavirus large T antigen. Cell Growth Differ. 5:231–237.
   PubMedGoogle Scholar
• Mal, A., R. Y. Poon, P. H. Howe, H. Toyoshima, T. Hunter, and J. Harter 1996. Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFβ-treated cells. Nature 380:262–265.
   PubMedGoogle Scholar
• Mancini, M. A., B. Shan, J. A. Nickerson, S. Penman, and J. Lee 1994. The retinoblastoma gene product is a cell cycle-dependent, nuclear matrix-associated protein. Proc. Natl. Acad. Sci. USA 91:418–422.
   PubMed Web of Science ®Google Scholar
• Martelli, F., C. Cenciarelli, G. Santarelli, B. Polikar, A. Felsani, and J. Caruso 1994. MyoD induces retinoblastoma gene expression during myogenic differentiation. Oncogene 9:3579–3590.
   PubMed Web of Science ®Google Scholar
• Matsuoka, S., M. Yamaguchi, and J. Matsukage 1994. D-type cyclin-binding regions of proliferating cell nuclear antigen. J. Biol. Chem. 269:11030–11036.
   PubMedGoogle Scholar
• Matsushime, H., M. E. Ewen, D. K. Strom, J. Y. Kato, S. K. Hanks, M. F. Roussel, and J. Sherr 1992. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 71:323–334.
   PubMed Web of Science ®Google Scholar
• Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Kato 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066–2076.
   PubMed Web of Science ®Google Scholar
• Matsushime, H., M. F. Roussel, R. A. Ashmun, and J. Sherr 1991. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701–713.
   PubMed Web of Science ®Google Scholar
• Meyerson, M., and J. Harlow 1994. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol. 14:2077–2086.
   PubMed Web of Science ®Google Scholar
• Missero, C., E. Calautti, R. Eckner, J. Chin, L. H. Tsai, D. M. Livingston, and J. Dotto 1995. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA 92:5451–5455.
   PubMed Web of Science ®Google Scholar
• Mittnacht, S., and J. Weinberg 1991. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell 65:381–393.
   PubMed Web of Science ®Google Scholar
• Morgan, D. O. 1995. Principles of CDK regulation. Nature 374:131–134.
   PubMed Web of Science ®Google Scholar
• Morgenstern, J. P., and J. Land 1990. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:3587–3596.
   PubMed Web of Science ®Google Scholar
• Mymryk, J. S., R. W. Lee, and J. Bayley 1992. Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein. Mol. Biol. Cell 3:1107–1115.
   PubMedGoogle Scholar
• Norbury, C., and J. Nurse 1992. Animal cell cycles and their control. Annu. Rev. Biochem. 61:441–470.
   PubMed Web of Science ®Google Scholar
• Novitch, B. G., G. J. Mulligan, T. Jacks, and J. Lassar 1996. Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in S and G2 phases of the cell cycle. J. Cell Biol. 135:441–456.
   PubMed Web of Science ®Google Scholar
• Ohtani, K., J. DeGregori, and J. Nevins 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92:12146–12150.
   PubMed Web of Science ®Google Scholar
• Olson, E. N., and J. Klein 1994. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8:1–8.
   PubMed Web of Science ®Google Scholar
• Otten, A. D., E. J. Firpo, A. N. Gerber, L. L. Brody, J. M. Roberts, and J. Tapscott 1997. Inactivation of MyoD-mediated expression of p21 in tumor cell lines. Cell Growth Differ. 8:1151–1160.
   PubMedGoogle Scholar
• Pagano, M., R. Pepperkok, J. Lukas, V. Baldin, W. Ansorge, J. Bartek, and J. Draetta 1993. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J. Cell Biol. 121:101–111.
   PubMed Web of Science ®Google Scholar
• Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and J. Draetta 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11:961–971.
   PubMed Web of Science ®Google Scholar
• Pagano, M., A. M. Theodoras, S. W. Tam, and J. Draetta 1994. Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev. 8:1627–1639.
   PubMed Web of Science ®Google Scholar
• Parker, S. B., G. Eichele, P. Zhang, A. Rawls, A. T. Sands, A. Bradley, E. N. Olson, J. W. Harper, and J. Elledge 1995. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267:1024–1027.
   PubMed Web of Science ®Google Scholar
• Phelps, D. E., K. M. Hsiao, Y. Li, N. P. Hu, D. S. Franklin, E. Westphal, E. Y. Lee, and J. Xiong 1998. Coupled transcriptional and translational control of cyclin-dependent kinase inhibitor p18INK4c expression during myogenesis. Mol. Cell. Biol. 18:2334–2343.
   PubMedGoogle Scholar
• Puri, P. L., M. L. Avantaggiati, C. Balsano, N. Sang, A. Graessmann, A. Giordano, and J. Levrero 1997. p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J. 16:369–383.
   PubMed Web of Science ®Google Scholar
• Puri, P. L., L. Cimino, M. Fulco, C. Zimmerman, N. B. La Thangue, A. Giordano, A. Graessmann, and J. Levrero 1998. Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation. Cancer Res. 58:1325–1331.
   PubMed Web of Science ®Google Scholar
• Puri, P. L., V. Sartorelli, X. J. Yang, Y. Hamamori, V. V. Ogryzko, B. H. Howard, L. Kedes, J. Y. Wang, A. Graessmann, Y. Nakatani, and J. Levrero 1997. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell 1:35–45.
   PubMed Web of Science ®Google Scholar
• Rao, S. S., C. Chu, and J. Kohtz 1994. Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators. Mol. Cell. Biol. 14:5259–5267.
   PubMedGoogle Scholar
• Rao, S. S., and J. Kohtz 1995. Positive and negative regulation of D-type cyclin expression in skeletal myoblasts by basic fibroblast growth factor and transforming growth factor beta. A role for cyclin D1 in control of myoblast differentiation. J. Biol. Chem. 270:4093–4100.
   PubMedGoogle Scholar
• Reed, S. I. 1992. The role of p34 kinases in the G1 to S-phase transition. Annu. Rev. Cell Biol. 8:529–561.
   PubMedGoogle Scholar
• Riley, D. J., E. Y. Lee, and J. Lee 1994. The retinoblastoma protein: more than a tumor suppressor. Annu. Rev. Cell Biol. 10:1–29.
   PubMedGoogle Scholar
• Rosenthal, N. 1987. Identification of regulatory elements of cloned genes with functional assays. Methods Enzymol. 152:704–720.
   PubMed Web of Science ®Google Scholar
• Samuels, H. H., F. Stanley, and J. Casanova 1979. Depletion of L-3,5,3′-triiodothyronine and l-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105:80–85.
   PubMed Web of Science ®Google Scholar
• Sanchez, I., and J. Dynlacht 1996. Transcriptional control of the cell cycle. Curr. Opin. Cell Biol. 8:318–324.
   PubMed Web of Science ®Google Scholar
• Sartorelli, V., J. Huang, Y. Hamamori, and J. Kedes 1997. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol. Cell. Biol. 17:1010–1026.
   PubMed Web of Science ®Google Scholar
• Schneider, J. W., W. Gu, L. Zhu, V. Mahdavi, and J. Nadal-Ginard 1994. Reversal of terminal differentiation mediated by p107 in Rb−/− muscle cells. Science 264:1467–1471.
   PubMed Web of Science ®Google Scholar
• Schulze, A., K. Zerfass, D. Spitkovsky, S. Middendorp, J. Berges, K. Helin, P. Jansen-Durr, and J. Henglein 1995. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl. Acad. Sci. USA 92:11264–11268.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J. 1994. G1 phase progression: cycling on cue. Cell 79:551–555.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and J. Roberts 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1149–1163.
   PubMed Web of Science ®Google Scholar
• Skapek, S. X., J. Rhee, D. B. Spicer, and J. Lassar 1995. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022–1024.
   PubMed Web of Science ®Google Scholar
• Tedesco, D., L. Baron, L. Fischer-Fantuzzi, and J. Vesco 1997. Induction of cyclins E and A in response to mitogen removal: a basic alteration associated with the arrest of differentiation of C2 myoblasts transformed by simian virus 40 large T antigen. J. Virol. 71:2217–2224.
   PubMedGoogle Scholar
• Tedesco, D., M. Caruso, L. Fischer-Fantuzzi, and J. Vesco 1995. The inhibition of cultured myoblast differentiation by the simian virus 40 large T antigen occurs after myogenin expression and Rb up-regulation and is not exerted by transformation-competent cytoplasmic mutants. J. Virol. 69:6947–6957.
   PubMedGoogle Scholar
• Thomas, P. S. 1980. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA 77:5201–5205.
   PubMed Web of Science ®Google Scholar
• Thorburn, A. M., P. A. Walton, and J. Feramisco 1993. MyoD induced cell cycle arrest is associated with increased nuclear affinity of the Rb protein. Mol. Biol. Cell 4:705–713.
   PubMedGoogle Scholar
• Tiainen, M., D. Spitkovsky, P. Jansen-Dürr, A. Sacchi, and J. Crescenzi 1996. Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms. Mol. Cell. Biol. 16:5302–5312.
   PubMedGoogle Scholar
• Tsai, L. H., E. Lees, B. Faha, E. Harlow, and J. Riabowol 1993. The cdk2 kinase is required for the G1-to-S transition in mammalian cells. Oncogene 8:1593–1602.
   PubMed Web of Science ®Google Scholar
• Waga, S., G. J. Hannon, D. Beach, and J. Stillman 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574–578.
   PubMed Web of Science ®Google Scholar
• Wang, H. G., Y. Rikitake, M. C. Carter, P. Yaciuk, S. E. Abraham, B. Zerler, and J. Moran 1993. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J. Virol. 67:476–488.
   PubMedGoogle Scholar
• Wang, J., and J. Nadal-Ginard 1995. Regulation of cyclins and p34CDC2 expression during terminal differentiation of C2C12 myocytes. Biochem. Biophys. Res. Commun. 206:82–88.
   PubMedGoogle Scholar
• Wang, J., and J. Walsh 1996. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex. Cell Growth Differ. 7:1471–1478.
   PubMedGoogle Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• Weintraub, H. 1993. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75:1241–1244.
   PubMed Web of Science ®Google Scholar
• Weintraub, H., T. Genetta, and J. Kadesch 1994. Tissue-specific gene activation by MyoD: determination of specificity by cis-acting repression elements. Genes Dev. 8:2203–2211.
   PubMed Web of Science ®Google Scholar
• Whyte, P., N. M. Williamson, and J. Harlow 1989. Cellular targets for transformation by the adenovirus E1A proteins. Cell 56:67–75.
   PubMed Web of Science ®Google Scholar
• Wigler, M., S. Silverstein, L. S. Lee, A. Pellicer, Y. C. Cheg, and J. Axel 1977. Transfer of purified Herpes virus thymidine kinase gene to cultured mouse cells. Cell 11:223–232.
   PubMed Web of Science ®Google Scholar
• Wright, W. E., M. Binder, and J. Funk 1991. Cyclic amplification and selection of targets (CASTing) for the myogenin consensus binding site. Mol. Cell. Biol. 11:4104–4110.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., H. Zhang, and J. Beach 1992. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71:505–514.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., H. Zhang, and J. Beach 1993. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev. 7:1572–1583.
   PubMed Web of Science ®Google Scholar
• Yaffe, D., and J. Saxel 1977. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270:725–727.
   PubMed Web of Science ®Google Scholar
• Yuan, W., G. Condorelli, M. Caruso, A. Felsani, and J. Giordano 1996. Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem. 271:9009–9013.
   PubMed Web of Science ®Google Scholar
• Zerfass-Thome, K., A. Schulze, W. Zwerschke, B. Vogt, K. Helin, J. Bartek, B. Henglein, and J. Jansen-Durr 1997. p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol. Cell. Biol. 17:407–415.
   PubMedGoogle Scholar
• Zerfass, K., D. Spitkovsky, A. Schulze, S. Joswig, B. Henglein, and J. Jansen-Durr 1996. Adenovirus E1A activates cyclin A gene transcription in the absence of growth factors through interaction with p107. J. Virol. 70:2637–2642.
   PubMedGoogle Scholar
• Zindy, F., E. Lamas, X. Chenivesse, J. Sobczak, J. Wang, D. Fesquet, B. Henglein, and J. Brechot 1992. Cyclin A is required in S phase in normal epithelial cells. Biochem. Biophys. Res. Commun. 182:1144–1154.
   PubMed Web of Science ®Google Scholar